BioNascent

San Francisco, United States Founded: 2016 • Age: 10 yrs
Infant health products based on breast milk proteins are developed.

About BioNascent

BioNascent is a Healthcare company based in San Francisco (United States) founded in 2016. Infant health products based on breast milk proteins are developed. It operates in the Healthcare and Consumer sectors. BioNascent has raised $250 thousand across 1 funding round from investors including IndieBio. BioNascent offers products and services including Startup Blog Platform and Article Publishing Service. Its focus areas include Life Sciences, Nutraceuticals Tech, Functional Foods and Beverages and Probiotic Drinks. Its competitors include Bobbie, Prolacta Bioscience and Candy Club; 2 of its 3 listed competitors have raised funding.

Company details

BioNascent was founded in 2016 in San Francisco, United States, within the biotechnology sector focused on infant nutrition. Products aimed at supporting infant health are developed and commercialized, including an infant formula derived from key proteins in human breast milk whey, such as alpha-lactalbumin, osteopontin, and lysozyme C. Operations center on providing alternatives to breastfeeding through these specialized formulations.

Key Metrics
  • Total Equity Funding
    $250K (USD)

    in 1 rounds

  • Latest Funding Round
    $250K (USD), Seed

    May 2016

  • Investors

Products & Services of BioNascent

BioNascent offers a comprehensive portfolio of products and services, including Startup Blog Platform and Article Publishing Service.

Startup Blog Platform
Online Content Service

Website delivering daily articles on business and lifestyle topics.

Article Publishing Service
Digital Media

Platform for sharing educational content across multiple categories.

Funding Insights of BioNascent

BioNascent has successfully raised a total of $250K through 1 strategic funding round. The most recent funding activity was a Seed round of $250 thousand completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $250,000
  • Total Rounds 1
  • Last Round Seed β€” $250,000
  • First Round $250,000

    (May 2016)

  • Investors Count 1

All 1 funding rounds of BioNascent with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2016$250,000Seed––
Valuation history

1 investors in total: 1 institutional.

Investors in BioNascent

BioNascent has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Biotech startups are accelerated through IndieBio's focused programs.
indiebio.coSan Francisco, United States
Premium access

Investor details for BioNascent

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of BioNascent

2 dated milestones of BioNascent, from founding to its latest funding, stage changes and deals.

  1. Founded BioNascent is founded.
  2. Funding First funding round of $250K.

Competitors of BioNascent

BioNascent has 3 listed competitors in our database, 2 of them funded. They include Bobbie, Prolacta Bioscience and Candy Club.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
hibobbie.com2017San Francisco, United States$127.63M
Organic milk-based baby formula powder is offered via online subscription.
prolacta.com1999Los Angeles, United States$97.88M
Human milk-based nutritional products for premature infants are developed.
candyclub.com2013Los Angeles, United States3
Monthly subscriptions of candy products are provided by Candy Club.
Premium access

Detailed competitors of BioNascent

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as BioNascent (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapies for metabolic health in chronic disease patients are provided.
2014San Francisco, California, United StatesUSD 401.78 M910
Personalized gut health solutions are provided by ZOE.
2017New Castle, Pennsylvania, United StatesUSD 15 M
Machine learning-based bioinformatics solutions for health insights are provided.
2016Los Alamos, New Mexico, United StatesUSD 301.57 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bionascent

Premium access

Complete news archive for BioNascent

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioNascent

BioNascent was founded in 2016.

BioNascent is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

BioNascent is a funded company, having raised a total of $250K across 1 funding round to date. The company's 1st funding round was a Seed of $250K, raised on May 2016.

BioNascent was founded in 2016 in San Francisco, United States, within the biotechnology sector focused on infant nutrition. Products aimed at supporting infant health are developed and commercialized, including an infant formula derived from key proteins in human breast milk whey, such as alpha-lactalbumin, osteopontin, and lysozyme C. Operations center on providing alternatives to breastfeeding through these specialized formulations.

BioNascent's top competitors include Bobbie, Prolacta Bioscience and Candy Club.

BioNascent offers Startup Blog Platform and Article Publishing Service.

BioNascent has 1 investor. Key investors include IndieBio.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available